Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
26 June 2013Website:
http://www.nanostring.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/ADividend
Analysts recommendations
Institutional Ownership
Included in screeners
Similar companies
NSTG Latest News
Life science applications specialist NanoString (NASDAQ: NSTG ), which provides tools for discovery and translation research, announced that it has entered into a credit agreement with its existing lenders. Driving the need for such an arrangement was a bankruptcy filing at the beginning of the week.
Investors looking at today's price action in NanoString (NASDAQ: NSTG ) stock ought to be shaking their heads in amazement. Indeed, after announcing the company would be filing for bankruptcy protection on Monday, many thought the story with NanoString was over.
NanoString Technologies (NASDAQ: NSTG ) stock is taking a beating on Monday after the company announced a voluntary Chapter 11 bankruptcy filing. NanoString Technologies notes that this bankruptcy filing is the result of its lost litigation battles against 10x Genomics.
Seattle-based publicly traded biotech company NanoString Technologies said in a filing Friday that it plans to cut about 50 positions, or 9% of its workforce.
SEATTLE--(BUSINESS WIRE)--NanoString to present at November conferences.
NanoString Technologies, Inc. (NASDAQ:NSTG ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Doug Farrell - IR Brad Gray - President and CEO Tom Bailey - CFO Conference Call Participants Marta Nazarovets - JPMorgan Kyle Boucher - TD Cowen Catherine Schulte - Baird Evan Stampler - Stifel Alexander Vukasin - Canaccord Genuity Operator Good afternoon. My name is Krista and I'll be your conference operator today.
While the top- and bottom-line numbers for NanoString (NSTG) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
In stock trading, shorting is seen as a high-risk, high-reward strategy. This approach involves borrowing stocks, selling them, and betting on their price dropping to make a profit.
According to NanoString (NSTG), SMI's unique ability to interrogate both RNA and proteins at ultra-high plex with subcellular resolution has made it a one-of-a-kind tool.
NanoString's (NSTG) nCounter Analysis System facilitates bulk tissue transcriptome profiling, revealing the intricacies of the immune response through the nCounter Human Organ Transplant Panel.
What type of business is NanoString Technologies?
NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
What sector is NanoString Technologies in?
NanoString Technologies is in the Healthcare sector
What industry is NanoString Technologies in?
NanoString Technologies is in the Medical Instruments & Supplies industry
What country is NanoString Technologies from?
NanoString Technologies is headquartered in United States
When did NanoString Technologies go public?
NanoString Technologies initial public offering (IPO) was on 26 June 2013
What is NanoString Technologies website?
https://www.nanostring.com
Is NanoString Technologies in the S&P 500?
No, NanoString Technologies is not included in the S&P 500 index
Is NanoString Technologies in the NASDAQ 100?
No, NanoString Technologies is not included in the NASDAQ 100 index
Is NanoString Technologies in the Dow Jones?
No, NanoString Technologies is not included in the Dow Jones index
When was NanoString Technologies the previous earnings report?
No data
When does NanoString Technologies earnings report?
Next earnings report date is not announced yet